Richter Group
Manufacturing
Boasting a 120-year history, pharmaceutical manufacturing in Richter is at the forefront of the global industry in all respects.
The Company manufactures 2800 pharmaceuticals, including original, generic, biosimilar and licensed products.
Richter traditionally uses its in-house manuctured active ingredients in its medicines and various preparations, such as injections, creams, ointments. The company also produces significant quantities of APIs for sale.
Active substance manufacturing
The Active Ingredient Production Division involves 8 plants in Hungary, each producing intermediates and all but one produces active substances. Half of the plants are located in Budapest and the other half in Dorog, but the focus of API production is increasingly shifting to Dorog. Nearly a thousand people are involved in active substance manufacturing at the two sites.
We manufacture active ingredients for our wide range of gynecological products, central nervous system, cardiovascular, gastrointestinal, muscle relaxant, anti-allergic, hemostatic, wound treatment, fungicidal preparations, as well as cytostatics. We also work with materials of plant and animal origin, but today production takes place mostly by chemical and fermentation processes.
Budapest
The Company’s oldest active ingredient production base is in Budapest and it dates back to 115 years. Employing more than 400 people, currently four API plants (Chemistry I, Chemistry III, Biochemistry I and Biochemistry II) produce steroid and synthetic active substances and their intermediates, as well as active substances extracted from plants and animal organs.
The active ingredient of several of our traditional and well-known products are manufactured in our Budapest facilities. These include the API of wound treatment Curiosin, our popular muscle relaxant and cerebral vasodilator, as well as many of our gynecological preparations.
Dorog
The Dorog plant has belonged to Richter for more than 50 years and has since grown to become our largest active ingredient base. The four plants operating here (Synthetic Plant I, Synthetic Plant III, Steroid Plant and Steroid Plant II) produce self-manufactured steroid and synthetic active ingredients and intermediates for formulations for use in a wide range of therapeutic areas.
The Dorog site has a total staff of 1,000, of which 500 work directly in production.As a result of the development of recent years, the Dorog plants have become fundamental to ensuring the supply of active ingredients for our Women’s Healthcare portfolio. Two steroid plants with a high level of steroid chemistry knowledge, manufacturing experience and a special technical base serve the needs of our gynecological strategic pillar with an ever-widening product range.
The API for one of our best-known products, Panangin, is also manufactured in Dorog, as well as most of our generic portfolio and our prorietary antipsychotic.
